OXYGENTA PHARMACEUTICAL LIMITEOXYGENTA PHARMACEUTICAL LIMITEOXYGENTA PHARMACEUTICAL LIMITE

OXYGENTA PHARMACEUTICAL LIMITE

No trades
See on Supercharts

OXYGENTAPH fundamentals

OXYGENTA PHARMACEUTICAL LIMITE financial statements, including revenue, expenses, profit, and loss

The total revenue of OXYGENTAPH for the last quarter is 105.52 M INR, and it's 14.97% higher compared to the previous quarter. The net income of Q4 23 is 80.16 M INR.

Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: INR
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth